Susquehanna International Group, LLP Bridge Bio Pharma, Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$23.91 - $31.3 $5.86 Million - $7.67 Million	-245,000 Reduced 28.77%	606,600 $15.4 Million
Q2 2024 Aug 15, 2024	BUY	$23.0 - $31.04 $7.5 Million - $10.1 Million	326,200 Added 62.09%	851,600 $21.6 Million
Q1 2024 May 07, 2024	BUY	$27.35 - $40.45 $4.13 Million - $6.11 Million	151,100 Added 40.37%	525,400 $16.2 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $696,580 - $1.27 Million	-29,000 Reduced 7.19%	374,300 $15.1 Million
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $1.72 Million - $3.56 Million	101,800 Added 33.76%	403,300 $10.6 Million
Q2 2023 Aug 11, 2023	SELL	$13.29 - $18.01 $523,625 - $709,594	-39,400 Reduced 11.56%	301,500 $5.19 Million
Q1 2023 May 16, 2023	BUY	$7.17 - $18.55 $2.13 Million - $5.51 Million	297,200 Added 680.09%	340,900 $5.65 Million
Q4 2022 Feb 14, 2023	BUY	$6.74 - $11.52 $57,290 - $97,920	8,500 Added 24.15%	43,700 $332,000
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $882,134 - $1.37 Million	-111,100 Reduced 75.94%	35,200 $350,000

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.23B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.